Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining 0.88% today. In the last week its performance is 0.80%, and -21.92% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 68.35, so today’s gain of 0.88% is a significant step towards its target price. The GAP today is therefore 0.18%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 94897.31, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.30%.

At the current price of 56.42, it has a dividend yield of 2.69%, and its target price is 68.35. This is with a profit margin of 16.30%, and total debt/equity of 0.45. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 33.01, as well as a forward P/E of 18.83.

With a current EPS of 1.71, and a forecasted EPS growth for next year at 14.04%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 19.59%.

Performance for the year is -6.49%. Since its IPO date on 6/1/1972, the total performance to date is -17.06%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 10444600, while its average volume is 11125.67. Whilst the total gain today was 0.88%, it did have a day high of -26.84%.

Volatility for this week has been at 1.66%, and 1.95% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been 2.54%, while the 52-week-high has reached -26.84%.

Looking at its return of investments, which is 4.60%, and its return on assets is 9.00%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 20.80%. With a sales growth of 17.00% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.44, and has a current ratio of 1.6 and 1.4 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 1.69, and the P/S is 5.39, along with a P/B of 6.32. Meanwhile it has a p/cash of 20.4.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment